Funding for this research was provided by:
Australian Research Council (CE140100011)
National Health and Medical Research Council (1083942, 1140126, 1117766, 1113293)
Text and Data Mining valid from 2019-05-21
Received: 2 January 2019
Accepted: 21 April 2019
First Online: 21 May 2019
: Z.C., D.P.F. and J.M. declare that they are inventors on patents describing MR1 tetramers and MR1 ligands. The other authors declare no competing interests.